Zoetis starts construction of vaccine R&D and manufacturing center in Suzhou, China

Zoetis celebrated the start of construction on a combined global manufacturing and supply and R&D center in Suzhou, China, focusing on vaccines for swine, cattle, fish and companion animals. An interim R&D facility for aquaculture vaccines also opened nearby.

“Zoetis Inc. today celebrated the start of construction on a combined global manufacturing and supply and research and development center in Suzhou, China.”wallstreetreporter.com

• 1 source
• wallstreetreporter.comZoetis (NYSE: ZTS) to Expand Animal Vaccine Research and Manufacturing in Suzhou, ChinaJackApr 26, 2018

Summarized from public sources; check the original articles before acting on it.